Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TicAAA: Ticagrelor for Inhibition of Small Abdominal Aortic Aneurysm Growth
2013-002736-24Phase 2Completed
- Sponsor
- Uppsala University
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in abdominal aortic aneurysm (AAA) comparing Ticagrelor (Brilique) arm with Placebo arm (2 arms). Primary endpoint: Mean reduction in AAA volume growth rate. Started Oct 2013; status: completed.
02
Drugs
ticagrelor
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2013-002736-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002736-24.